Can a Light-Up mask turn back the clock on Sun-Damaged skin?
NCT ID NCT07661004
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether using an LED mask, alone or with a special serum, can reduce signs of facial aging like wrinkles and dullness. About 130 women aged 35 to 60 with mild to moderate sun damage will use the mask five times a week for three months. Researchers will measure changes in skin appearance through expert ratings, photos, and participant feedback.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- LED mask and cosmetic serum
- What this could lead to
- If effective, this could offer a non-invasive, at-home option to reduce wrinkles and improve skin radiance without drugs or procedures.
- What could go wrong
- This is a small, early-stage cosmetic study without a placebo control, so results may be modest or not generalizable. The mask requires consistent daily use for months.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 130 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2026
An estimate. Start dates often move.
- Expected to finish
-
Apr 2027
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
35 to 60 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Female subjects aged between 35-60y.o 2. Presenting all skin types 3. Presenting all phototype according to Fitzpatrick Classification 4. Sensitive skin (50%) - declarative 5. Daily user of SPF30 or 50+ for at least 30 days 6. User or not of LED masks (collected data) 7. Mask adapted to the shape of the face 8. Having mild to moderate scores (as indicated) for the items parameters 9. Subjects willing not to change their face/eyes make-up removal products and habits, and shower habits (e.g. shampoo, shower gel), and make-up products (eyes and mouth) throughout the course of the study. 10. Subjects willing to use the investigational devices and/or products on the face throughout the course of the study period 11. Subjects taking an effective oral contraception or other methods of contraception for the duration of the study 12. Written Informed Consent Form to participate in the study 13. illingness and ability to comply with protocol requirements Exclusion Criteria: 1. Subjects having allergy or sensitivity to LED Light 2. Subjects having at risk of epilepsy 3. subject who may have headaches 4. Subjects having participated in the clinical study using anti-aging formula on the face within at least 3 months preceding the baseline visit 5. Subjects having used any cosmetic products with exfoliating or astringing allegation on the face within at least 4 weeks preceding the baseline visit 6. Subject with arterial circulatory disorders in the treated area, 7. Subjects with sensitivity troubles and pain perception impairment, facial paralysis, 8. Subjects with degenerative and vascular retinal disease, 9. Subjects with known problems of scarring or wound healing, 10. History of photosensitivity or photo allergy 11. History of chronic viral infections (herpes simplex, ZONA…) and last outbreak within 12 months preceding the baseline visit 12. Subject having an underlying dermatological disease or conditions on the face, which in the investigator's opinion, could interfere with study evaluation 13. Subjects with a melanoma history in the family (parents or grandparents) 14. Subjects undergone the radiotherapy in the treated areas, 15. Subject having excessive moles, excessive pigmented spots, tattoos, scars, irritated skin, etc. at the test area that could influence the investigation 16. Subject with a history of surgery to the treatment concerned areas within 6 months preceding the baseline visit 17. Subject reports (or plans to) sunbath or overexpose to UV-light (mountains sports, phototherapy, tanning salon use…) for aesthetic or therapeutic reason one month before the study start (or during the study). 18. Subject having modified their cosmetic habits (moisturizing skin care, cleansers, make-up removers, make-up, shower products, shampoo…) during the 2 weeks before baseline visit. 19. Subject uses or has used any of the medications or topical treatments/skincare products/procedure below without relevant wash-out period before the baseline visit (or is unwilling or unable to accept to follow the wash-out period below during the study) \-
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Anti aging are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Eurofins CRL
Piscataway, New Jersey, 08854, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.